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Figure 1. A 10-cm lower pole ulceration with left breast implant extrusion.
Figure 2. Chest posteroanterior identifies a bone density round calcifica-
tion.
Figure 3. After careful dissection of the thin cutaneous flaps, a 1-
mm-thick exuberant and dense calcification was identified under the
capsule surface.
Figure 4. Hematoxylin and eosin coloration shows multilamellar crystal
calcium deposits with true bone formation and osteocyte lacunae.
DESCRIPTION
An 80-year-old woman with a reconstructed breast 28 years ago presented prosthetic
extrusion. Chest radiographs showed a round opacity with bone density. After implant
removal, the breast maintained a rigid conformation with exuberant calcification. The
massive calcification took the microscopic form of multilamellar crystal calcium deposits
with true bone formation.
QUESTIONS
1. What is heterotopic calcification?
2. Is massive heterotopic ossification a frequent finding?
3. What are the patient risk factors for breast implant calcification?
4. What are the implant characteristics that are implicated with a higher
risk of periprosthetic calcification?
DISCUSSION
In 1977, Peters et al described for the first time the calcification around breast implants and
its mechanism of deposition. It is a common reaction that affects 16% to 25% of removed
implants and it is associated with higher capsular contraction (Baker III and IV) and pain,
although many cases remain subclinical. The implant capsule is formed by thick collagen
fibers, inflammatory cells, histiocytes, and foreign-body giant cells; chondral metaplasia
and hyalinization may coexist. It is thought that there is a time-related cascade of events
until calcium deposits in the fibrous capsule: a strong histiocyte, macrophage, and foreign-
body giant cell reaction leads to synovial metaplasia after a median time of 11.7 years and
dystrophic calcification after 11 to 22 years.
Massive heterotopic calcification, characterized by an organized multilamellar deposi-
tion of hydroxyapatite crystals between collagen fibers, with osseous trabeculae surrounded
by osteoblasts and lacunae osteocyte apposition, is a rare finding. There are few case reports
describing this exuberant reaction in the literature.
The only host risk factor related to periprosthetic calcification is agemore than 60 years
at the time of surgery. The other factors identified are related to implant characteristics:
the type of filling (saline or silicone), the implant generation, the duration of the implant
in situ, and implant integrity. It appears to exist a causative relation between the rupture of
the implant envelope (or its decomposition) with a higher deposition of calcium crystals,
maybe by a more intense host reaction against silicone, Dacron, or polyurethane particles.
Hundred percent of first-generation breast implants (1963-1972) led to calcification of the
capsule after 14 years. Those implants had a thicker envelope and a Dacron patch; those
characteristics were reviewed, and second-generation implants (1973-1987) had a thinner
envelope and the Dacron patch was removed. That improved calcification rates: 0% before
11 years and 42% after 11 years in situ.
During the 1980s, the possibility of leakage of implants was of obvious concern, given
the well-known problems with silicone gel breast injections made during the 1940s and
1950s. Several journals published articles about severe capsular contracture, heterotopic
calcification, and serious connective tissue disorders after breast implant rupture or “bleed-
ing” of silicone and silica particles. After the Food and Drug Administration’s moratorium
that banned silicone implants in the United States during the 1990s, manufacturers devel-
oped implants with a triple-layer shell that prevented leakage, and a more cohesive gel.
These reintroduced implants (third generation) had almost no silicone leak, and a dramatic
decrease in heterotopic ossification was noticed since then, making it a rare finding. Re-
cent third-generation implants (after 1987) still lack large, randomized studies; however,
the literature points to calcification deposits in 5% to 30% after 11 years in situ and 0%
before that. Calcification takes 1 of 2 forms: globular aggregates and heterotopic bone.
The former are found in saline prosthesis in the entire capsule surface and in silicone
prosthesis restricted to the anterior surface; the latter was identified only in the anterior
surface of silicone prosthesis. This patient presented an ulcer on a reconstructed breast with
second-generation silicone prosthesis, 28 years before, following a radical mastectomy for
breast cancer. The breast was very stiff, and the prosthesis could not be felt by external pal-
pation. After prosthesis removal, the breast maintained the same rigid and nondepressible
conformation. After careful dissection of the thin cutaneous flaps, a 1-mm-thick exuberant
and dense calcification was identified under the capsule surface. The posterior wall of the
prosthetic capsule was less involved. The mandatory capsulectomy was performed and the
breast flaps were sutured to the anterior chest wall, under suction drainage.
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